Overnight Trade Opportunity Next Week?!
I'm looking at a BIG Overnight Trade opportunity next week...It's so big...

I'm going to give it to you FREE!

In fact, for the week of October 4-8, you can join our FREE Open House!

You can get ALL our Overnight Trade recommendations, plus ALL of our research and real-time recommendations!
Go Here to Join.
pixel

EVOK Insider Trading (Evoke Pharma)

Insider Ownership Percentage: 8.03%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $226,405.01

Evoke Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Evoke Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Evoke Pharma Share Price & Price History

Current Price: $1.35
Price Change: Price Increase of +0.06 (4.65%)
As of 09/24/2021 01:00 AM ET

This chart shows the closing price history over time for EVOK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The “Tech Royalty” Retirement Plan Can Help You Live Like Royalty
For the first time ever, a new type of tech investment allows you to collect ongoing income. One former Wall Street insider calls them, “Tech Royalties.”

And new “Tech Royalty” savings accounts allow you to collect as much as 8%... 12%... and even 17% or more.
Find out why “Tech Royalties” may be the best asse

Evoke Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/14/2020David A GonyerCEOSell23,954$2.94$70,424.76363,736View SEC Filing Icon  
12/11/2020David A GonyerCEOSell48,046$2.90$139,333.40363,736View SEC Filing Icon  
12/10/2020Matthew J D'onofrioVPSell5,643$2.95$16,646.85324,354View SEC Filing Icon  
See Full Table
Insider Trading at Evoke Pharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Evoke Pharma and related companies.

SEC Filings (Institutional Ownership Changes) for Evoke Pharma (NASDAQ:EVOK)

13.89% of Evoke Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at EVOK by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Evoke Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/23/2021Morgan Stanley582,611$0.80M0.0%-19.5%1.796%Search for SEC Filing on Google Icon
8/17/2021Worth Venture Partners LLC397,742$0.55M0.2%+18.2%1.229%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley582,611$0.80M0.0%-19.5%1.800%Search for SEC Filing on Google Icon
8/16/2021Sabby Management LLC47,431$65K0.0%N/A0.147%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC195,760$0.27M0.0%+22.4%0.605%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,120,178$1.53M0.0%-1.5%3.460%Search for SEC Filing on Google Icon
8/12/2021AIGH Capital Management LLC1,701,185$2.33M0.4%+18.7%5.255%Search for SEC Filing on Google Icon
5/20/2021Axiom Investment Management LLC17,500$32K0.0%N/A0.054%Search for SEC Filing on Google Icon
5/19/2021Worth Venture Partners LLC336,516$0.62M0.3%N/A1.040%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley723,897$1.33M0.0%+43.6%2.236%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC18,044$33K0.0%N/A0.056%Search for SEC Filing on Google Icon
5/13/2021Axiom Investment Management LLC17,500$32K0.0%N/A0.054%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG31,757$58K0.0%+1,709.5%0.098%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.150,891$0.28M0.0%+8.2%0.466%Search for SEC Filing on Google Icon
4/9/2021Pure Financial Advisors Inc.17,647$32K0.0%N/A0.055%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC18,335$47K0.0%N/A0.069%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC187,276$0.48M0.0%+739.8%0.710%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN25,117$65K0.0%+17,840.7%0.095%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.139,474$0.36M0.0%+8.7%0.529%Search for SEC Filing on Google Icon
11/13/2020Morgan Stanley92,920$0.44M0.0%+250.9%0.352%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.128,275$0.60M0.0%-35.7%0.493%Search for SEC Filing on Google Icon
8/12/2020Goldman Sachs Group Inc.35,174$0.13M0.0%N/A0.135%Search for SEC Filing on Google Icon
5/8/2020Cetera Advisor Networks LLC28,260$33K0.0%+108.4%0.116%Search for SEC Filing on Google Icon
4/28/2020State of Michigan Retirement System464$0.40M0.2%-99.9%0.002%Search for SEC Filing on Google Icon
2/4/2020Virtu Financial LLC43,210$70K0.0%N/A0.178%Search for SEC Filing on Google Icon
8/14/2019Citadel Advisors LLC59,047$37K0.0%N/A0.254%Search for SEC Filing on Google Icon
8/14/2019Vanguard Group Inc.224,797$0.14M0.0%-64.7%0.966%Search for SEC Filing on Google Icon
8/13/2019BlackRock Inc.51,636$32K0.0%-39.1%0.222%Search for SEC Filing on Google Icon
6/16/2019Marshall Wace LLP92,406$0.14M0.0%N/A0.397%Search for SEC Filing on Google Icon
4/12/2019Virtu Financial LLC78,787$0.12M0.0%N/A0.452%Search for SEC Filing on Google Icon
2/8/2019BlackRock Inc.83,583$0.21M0.0%+5.5%0.480%Search for SEC Filing on Google Icon
1/29/2019Wambolt & Associates LLC33,165$82K0.1%N/A0.190%Search for SEC Filing on Google Icon
11/7/2018JPMorgan Chase & Co.37,323$0.11M0.0%N/A0.221%Search for SEC Filing on Google Icon
5/10/2018Sphera Funds Management LTD.393,852$0.82M0.1%-48.8%2.543%Search for SEC Filing on Google Icon
2/15/2018683 Capital Management LLC114,300$0.26M0.0%N/A0.742%Search for SEC Filing on Google Icon
2/14/2018Deutsche Bank AG200,000$0.45M0.0%N/A1.298%Search for SEC Filing on Google Icon
2/12/2018Sphera Funds Management LTD.769,149$1.74M0.2%+34.7%4.991%Search for SEC Filing on Google Icon
2/10/2018B. Riley Financial Inc.110,000$0.25M0.1%N/A0.714%Search for SEC Filing on Google Icon
1/17/2018Creative Planning100,000$0.23M0.0%N/A0.649%Search for SEC Filing on Google Icon
11/9/2017Sphera Funds Management LTD.571,022$1.91M0.3%+14.2%3.710%Search for SEC Filing on Google Icon
8/14/2017Precept Management LLC95,000$0.24M0.1%No Change0.617%Search for SEC Filing on Google Icon
8/9/2017Sphera Funds Management LTD.500,000$1.28M0.2%No Change3.249%Search for SEC Filing on Google Icon
7/19/2017State Treasurer State of Michigan400,000$1.02M0.0%+37.0%2.599%Search for SEC Filing on Google Icon
5/11/2017California Public Employees Retirement System36,700$0.11M0.0%No Change0.298%Search for SEC Filing on Google Icon
5/11/2017Sphera Funds Management LTD.500,000$1.55M0.3%N/A4.063%Search for SEC Filing on Google Icon
5/1/2017State Treasurer State of Michigan291,966$0.91M0.0%+62.2%2.373%Search for SEC Filing on Google Icon
11/2/2016State Treasurer State of Michigan140,000$0.32M0.0%+460.0%1.134%Search for SEC Filing on Google Icon
8/3/2016State Treasurer State of Michigan25,000$0.17M0.0%N/A0.345%Search for SEC Filing on Google Icon
5/27/2016Opaleye Management Inc.130,000$0.66M0.4%No Change1.796%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Evoke Pharma logo
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
Read More on Evoke Pharma

Today's Range

Now: $1.35
Low: $1.24
High: $1.35

50 Day Range

MA: $1.14
Low: $1.04
High: $1.35

52 Week Range

Now: $1.35
Low: $0.96
High: $5.00

Volume

148,143 shs

Average Volume

126,892 shs

Market Capitalization

$43.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Evoke Pharma?

Evoke Pharma's top insider investors include:
  1. David A Gonyer (CEO)
  2. Matthew J D'onofrio (VP)

Who are the major institutional investors of Evoke Pharma?

Evoke Pharma's top institutional investors include:
  1. AIGH Capital Management LLC — 5.26%
  2. Vanguard Group Inc. — 3.46%
  3. Morgan Stanley — 1.80%
  4. Morgan Stanley — 1.80%
  5. Worth Venture Partners LLC — 1.23%
  6. Geode Capital Management LLC — 0.60%

Which institutional investors are selling Evoke Pharma stock?

In the previous quarter, EVOK stock was sold by these institutional investors:
  1. Morgan Stanley
  2. Morgan Stanley
  3. Vanguard Group Inc.
  4. Citadel Advisors LLC
In the previous year, company insiders that have sold Evoke Pharma company stock include:
  1. David A Gonyer (CEO)
  2. Matthew J D'onofrio (VP)

Which institutional investors are buying Evoke Pharma stock?

In the last quarter, EVOK stock was purchased by institutional investors including:
  1. AIGH Capital Management LLC
  2. Worth Venture Partners LLC
  3. Sabby Management LLC
  4. Geode Capital Management LLC
Overnight Trade Opportunity Next Week?!
I'm looking at a BIG Overnight Trade opportunity next week...It's so big...

I'm going to give it to you FREE!

In fact, for the week of October 4-8, you can join our FREE Open House!

You can get ALL our Overnight Trade recommendations, plus ALL of our research and real-time recommendations!
Go Here to Join.
pixel